Hot Life Sciences Stocks To Invest In 2015

Pall Corporation (PLL) is a supplier of filtration, separation and purification technologies, principally made by the company, for the removal of solid, liquid and gaseous contaminants from a range of liquids and gases. The company serves customers through two businesses globally: Life Sciences and Industrial. While Pall competes with many companies in the Life Sciences markets and Industrial, few companies operate in both, like ESCO Technologies Inc. (ESE) and Danaher Corp. (DHR).

In this article, let's take a look at this company and try to explain to investors the reasons this is an apparently appealing investment.

Cost Reduction

Pall targeted $100 million in structural cost reductions over the next three years. It saved $50 million during fiscal 2013 by reducing SG&A expenses along with other costs. It expects to save another $50 million in the next couple of years. Further, we think new management is going to focus on improving the company's cost structure in emerging markets as well. Moreover, Pall will focus on markets such as Asia, expanding its outsourcing network in low-cost countries.

Hot Life Sciences Stocks To Invest In 2015: BioCryst Pharmaceuticals Inc.(BCRX)

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Advisors' Opinion:

• [By GuruFocus]

  George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) - 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) - 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) - 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) - 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) - 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.27, with an estimated

• [By Roberto Pedone]

  Another under-$10 name in the bio therapeutic space that's starting to move within range of triggering a major breakout trade is BioCryst Pharmaceuticals (BCRX), which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. This stock has been on fire so far in 2013, with shares up a whopping 380%.

  If you take a look at the chart for BioCryst Pharmaceuticals, you'll notice that this stock recently formed a double bottom chart pattern at $6.07 to $6.24 a share. Following that bottom, shares of BCRX are now starting to spike higher right off its 50-day moving average of $6.50 a share. That spike is quickly pushing shares of BCRX within range of triggering a major breakout trade.

  Market players should now look for long-biased trades in BCRX if it manages to break out above some near-term overhead resistance levels at $6.88 to $6.89 a share, and then once it takes out more resistance at $7.56 to its 52-week high at $7.80 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2.51 million shares. If that breakout triggers soon, then BCRX will set up to enter new 52-week-high territory above $7.80, which is bullish technical price action. Some possible upside targets off that breakout are $10 to $12 a share.

  Traders can look to buy BCRX off weakness to anticipate that breakout and simply use a stop that sits right below those key near-term support levels at $6.24 to $6.07 a share. One can also buy BCRX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Sean Williams]

  Perhaps no shareholders jumped for more joy over the past week than those of BioCryst Pharmaceuticals (NASDAQ: BCRX  ) , whose shares shot up 88% this week on word of a positive early-stage clinical trial for BCX4161. In a different context, shares have now jumped 155% in just the past two weeks. The oral experimental drug, BCX4161, which is designed to treat a rare condition known as hereditary angioedema (HAE), was considered safe and well tolerated among patients, and the company anticipates moving on to mid-stage testing soon. However, as the Fools Brian Orelli was quick to point out, this data came from a subset of healthy volunteers, and there's little guarantee it will translate into success in future trials on patients that do suffer from HAE.

• [By John Udovich]

  While the Twitter IPO has been grabing everyone�� attention, biotech IPOs continue to dominate both biotech and IPO news with Karyopharm Therapeutics Inc (NASDAQ: KPTI) going public yesterday and�Relypsa (NASDAQ: RLYP), TetraLogic Pharmaceuticals (NASDAQ: TLOG), Vital Therapies (NASDAQ: VTL) and Xencor (NASDAQ: XNCR) filing to go public in the near future�(despite the sector producing some�ugly charts�for the month of October) plus�another small cap called TNI BioTech (OTCMKTS: TNIB) has also been producing a steady flow of news:

  Karyopharm Therapeutics Debuts. Yesterday, small cap Karyopharm Therapeutics, which is working on a drug that aids the body�� natural tumor-suppressing proteins,�debuted at the top of�its range to raise $109 million in an upsized�offering of 6.8 million shares at $16 apiece with shares closing at $16.81. It should be noted that Karyopharm Therapeutics��lead drug candidate (Selinexor) is in early-stage clinical trials�and the company lost�lost nearly $12.5 million on revenue of $366,000 during the first six months of this year. Biotech IPOs by Region. On an interesting note, Luke Timmerman, the National Biotech Editor of Xconomy, has written a�good�article tracking biotech or life sciences IPOs by region. By his count, Boston is home to eight of the 45 (18%) of the life sciences IPOs this year (its companies have also�raised the most money - about $770 million)�plus�the New York/northern New Jersey region is also home to�eight. San Diego�came in third with six IPOs followed by San Francisco with five while only five of the 45 biotech IPOs�came from outside the�US (Three from Israel and two from Europe). However, the above figures may change as by his account, there are 15 additional biotech companies in line to go public. More Biotechs Set IPO Terms. The small cap biotech space is about to be joined by a few new additions as a couple of biotechs file to go public�over the past�week or so: Relypsa, which is d

Hot Life Sciences Stocks To Invest In 2015: AvalonBay Communities Inc. (AVB)

AvalonBay Communities, Inc. engages in the development, redevelopment, acquisition, ownership, and operation of multifamily communities in the United States. As of January 31, 2009, the company owned or held a direct or indirect ownership interest in 164 operating apartment communities comprising 45,728 apartment homes in 10 states and the District of Columbia. It also held a direct or indirect ownership interest in 14 communities under construction, as well as held rights to develop an additional 27 communities. The company?s markets are located in New England, the New York/New Jersey metro area, the Mid-Atlantic, the Midwest, the Pacific Northwest, and the Northern and Southern California regions of the United States. AvalonBay Communities has elected to be taxed as a real estate investment trust and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 1978 and is based in Arlington, Virginia.

Advisors' Opinion:

• [By Shauna O'Brien]

  KeyBanc announced on Thursday that it has boosted its rating on AvalonBay Communities Inc (AVB) to “Buy.”

  The firm has upgraded AVB from “Hold” to “Buy,” and has given the company a $139 price target. This price target suggests a 15% upside from the stock’s current price of $120.55. KeyBanc has also upgraded residential REIT UDR, Inc. (UDR) and has cut its rating on Essex Property Trust Inc (ESS).

  Analyst Karin Ford noted: “We upgrade the Apartment REIT vertical from Market-Weight to OVERWEIGHT based upon attractive valuation levels that overlook the potential for accelerating fundamentals, as the impact of new supply wanes and continued employment gains support greater rental demand into ’15.

  “We believe the short-cycle nature of the apartment vertical’s leases place it relatively well within an env’t of rising rates driven by an imprv�� economy; the group’s underperformance YTD and current relative valuation level (4% discount to REIT sector on AFFO multiple) reflects concern over slowing fundamentals amid elevated new supply. We think new supply should peak in late-’14 and give way to accelerating absorption trends.”

  AvalonBay Communities shares were mostly flat during pre-market trading Thursday. The stock is down 11% YTD.

• [By Aaron Levitt]

  When it comes to apartment REITs, AvalonBay Communities (AVB) is one of the largest. The firm has direct or indirect ownership in a massive 273 apartment communities, or roughly 81,500 different apartments or townhomes. The bulk of these buildings are located in markets with a high barrier to entry — Washington D.C., for example — and feature a stable and generally high-income renter�� base.

• [By Sean Williams]

  Everything's peachy for residential REITs!
  However, what terrible news exists for homebuilders could turn into fantastic news for the residential-REIT sector. You see, if lending rates begin to rise because the Fed is paring back its bond purchases, then it will remove the consumer incentive to purchase a home and will drive people back into renting -- which is great news for the big three residential REITS: Equity Residential, AvalonBay Communities (NYSE: AVB  ) , and UDR (NYSE: UDR  ) .

• [By Rich Duprey]

  Real estate investment trust�AvalonBay Communities� (NYSE: AVB  ) �announced yesterday�its second-quarter dividend of $1.07 per share, the same rate it paid last quarter after raising the payout 10%, from $0.97 per share.

Top 10 Paper Companies To Own In Right Now: USANA Health Sciences Inc.(USNA)

USANA Health Sciences, Inc. develops, manufactures, distributes, and sells nutritional and personal care products worldwide. It offers the USANA Nutritionals product line, which consists of essentials, which include vitamin and mineral supplements that provide a foundation of nutrition for various age groups; optimizers that are targeted supplements supporting needs, such as cardiovascular health, skeletal/structural health, and digestive health; and foods comprising low-glycemic meal replacement shakes, snack bars, and other related products that offer optimal macro-nutrition. Its Sense product line comprises personal care products that support healthy skin and hair. The company also offers materials and online tools, such as associate starter kit and product brochures that are designed to assist associates in building their businesses and in marketing our products. USANA Health Sciences, Inc. primarily distributes its products through a network marketing system of indepe ndent distributors. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Advisors' Opinion:

• [By Ben Levisohn]

  Shares of NuSkin (NUS), which has its own China problems, have fallen 2.6% to $71.10 at 1:38 p.m. after being up much of the day, while Usana Health Sciences (USNA) has dropped 5.78% to $68.80 after being up as well. Prices are moving fast, so these will have changed by the time you read this.

• [By John Kell]

  Usana Health Sciences Inc.'s(USNA) fourth-quarter profit increased 9.9% as the nutritional-products maker posted higher global sales, results that easily exceeded Wall Street’s expectations. Shares surged 15% to $67.35 premarket.

• [By Ben Levisohn]

  Shares of Nu Skin have gained 5.4% to $78.63, while Herblife�(HLF) has risen 1.5% to $66 and�Usana Health Sciences�(USNA) has advanced 5% to $75.53.

Hot Life Sciences Stocks To Invest In 2015: First Interstate BancSystem Inc.(FIBK)

First Interstate BancSystem, Inc. operates as the bank holding company for First Interstate Bank that provides commercial and consumer banking services. Its deposit products include checking, savings, time, and demand deposits; and repurchase agreements primarily for commercial and municipal depositors. The company?s loan portfolio consists of a mix of real estate, consumer, commercial, agricultural, and other loans, including fixed and variable rate loans. Its real estate loans comprise commercial real estate, construction, residential, agricultural, and other real estate loans. The company also provides a range of trust, employee benefit, investment management, insurance, agency, and custodial services to individuals, businesses, and nonprofit organizations. These services include the administration of estates and personal trusts; management of investment accounts for individuals, employee benefit plans, and charitable foundations; and insurance planning. It serves indi viduals, businesses, municipalities, and other entities in various industries, including energy, healthcare and professional services, education and governmental services, construction, mining, agriculture, retail and wholesale trade, and tourism. The company operates 72 banking offices in 42 communities located in Montana, Wyoming, and western South Dakota. First Interstate BancSystem, Inc. was incorporated in 1971 and is headquartered in Billings, Montana.

Advisors' Opinion:

• [By Zacks]

  Some better-ranked Midwest banks include First Interstate Bancsystem Inc. (NASDAQ: FIBK), Wintrust Financial Corporation (NASDAQ: WTFC) and PrivateBancorp, Inc. (NASDAQ: PVTB). All these stocks carry a Zacks Rank #1 (Strong Buy).

Hot Life Sciences Stocks To Invest In 2015: Consumer Staples Select Sector SPDR (XLP)

Consumer Staples Select Sector SPDR Fund (the Fund) seeks to provide investment results that correspond to the price and yield performance of the Consumer Staples Select Sector of the S&P 500 Index (the Index). The Index includes companies that are primarily involved in the development and production of consumer products that cover food and drug retailing, beverages, food products, tobacco, household products and personal products.

The Fund utilizes a passive or indexing investment approach to invest in a portfolio of stocks that seek to replicate the Index. The Fund�� investment advisor is SSgA Funds Management, Inc.

Advisors' Opinion:

• [By Chris Versace, Editor, PowerTrend Brief and PowerTrend Profits]

  That, to me, says they're going to favor inelastic goods over elastic ones, so when you think of the things that we need each and every day, toilet paper, toothpaste, deodorant, shampoo, household cleansers, that sort of thing, that's what brings me into (XLP) and (VDC).

Hot Life Sciences Stocks To Invest In 2015: PetroChina Company Limited(PTR)

PetroChina Company Limited produces and distributes oil and gas in the People?s Republic of China. It operates in four segments: Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline. The Exploration and Production segment explores, develops, produces, and markets crude oil and natural gas, oilsands, and coalbed methane. As of December 31, 2010, it had 11,278 million barrels of proved reserves of crude oil; and 65,503 billion cubic feet of proved reserves of natural gas. The Refining and Chemicals segment engages in the refining of crude oil and petroleum products; and production and marketing of petrochemical products, derivative petrochemical products, and other chemical products. This segment?s product line comprises processed crude oil, gasoline, kerosene, diesel, ethylene, synthetic resins, synthetic fiber materials, polymers, synthetic rubber, and urea. The Marketing segment involves in the marketing of refined products and tradi ng businesses. It operated 17,996 service stations. The Natural Gas and Pipeline segment engages in the transmission of natural gas, crude oil, and refined products; and the sale of natural gas. It had a total length of 56,840 kilometers (km) of oil and gas pipelines, including 32,801 km of natural gas pipelines, 14,782 km of crude oil pipelines, and 9,257 km of refined product pipelines. The company was founded in 1988 and is headquartered in Beijing, the People?s Republic of China. PetroChina Company Limited is a subsidiary of China National Petroleum Corporation.

Advisors' Opinion:

• [By Jonas Elmerraji]

  First up is Chinese oil and gas giant PetroChina (PTR). Saying PetroChina has seen a rough 2013 is an understatement. Year-to-date, shares of the $203 billion firm have slipped more than 22% at the same time that the S&P 500 has been in rally mode. But shareholders could be in store for a reprieve this winter thanks to a bullish setup that's been forming in shares of late.

  PetroChina is currently forming an ascending triangle bottom, a trading setup that's formed by a horizontal resistance level to the upside at $118 and uptrending support below shares. Basically, as PTR bounces between those two levels, it's getting squeezed closer and closer to a breakout above the $118 price ceiling. When that breakout happens, it's time to be a buyer.

  Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.

  That $28 resistance level is a price where there has been an excess of supply of shares; in other words, it's a place where sellers had been more eager to step in and take gains than buyers were to buy. That's what makes this week's breakout above it so significant. The move means that buyers are finally strong enough to absorb all of the excess supply above that price level.

  If you decide to take the Pandora trade, I'd recommend keeping a protective stop at the 50-day moving average.

• [By GuruFocus]

  PetroChina Co. Ltd. (PTR) Reached the 52-Week Low of $99.78

  The prices of PetroChina Co. Ltd. (PTR) shares have declined to close to the 52-week low of $99.78, which is 31.4% off the 52-week high of $144.23. PetroChina Co. Ltd. is owned by eight Gurus we are tracking. Among them, three have added to their positions during the past quarter. Four reduced their positions. PetroChina was established as a joint stock company on Nov. 5, 1999. Petrochina Co. Ltd. has a market cap of $182.62 billion; its shares were traded at around $99.78 with a P/E ratio of 11.40 and P/S ratio of 0.49. The dividend yield of Petrochina Co. Ltd. stocks is 4.23%. Petrochina Co. Ltd. had an annual average earnings growth of 6.90% over the past 10 years. GuruFocus rated Petrochina Co. Ltd.�the business predictability rank of 3.5-star.

• [By GuruFocus]

  In the past you have made a few investments in China, Petrol China (PTR), BYD, given growing importance, what advice would you give to Chinese leadership?

• [By vaninaegea]

  I find the analysis and comparison between companies with base in different geographies an entertaining exercise that offers a singular perspective upon future prospects. In other words, business activities are approached from diverse angles according to social, political, and economical background. Hence, Petroleo Brasileiro (PBR) and PetroChina (PTR) do compete in the same segments, but results are separated by a gamut of particularities.

Hot Life Sciences Stocks To Invest In 2015: HopFed Bancorp Inc.(HFBC)

HopFed Bancorp, Inc. operates as the holding company for Heritage Bank that provides various banking products and services primarily in western Kentucky, and middle and western Tennessee. The company offers a range of deposit products, including demand deposits, time deposits, money market accounts, passbook savings accounts, individual retirement accounts, and certificates of deposit. Its loan portfolio comprises one-to-four family residential loans, multifamily residential loans, construction loans, nonresidential loans, commercial real estate loans, and land and land development loans, as well as loans secured by deposits, other consumer loans, and commercial loans. The company, through its subsidiary, Fall and Fall Insurance Agency, sells life and casualty insurance products to individuals and businesses. HopFed Bancorp offers its products and services through its branch offices located in Hopkinsville, Murray, Cadiz, Elkton, Fulton, Calvert City, and Benton, Kentucky; and in Clarksville, Pleasant View, Ashland City, Kingston Springs, and Erin, Tennessee. The company was founded in 1879 and is headquartered in Hopkinsville, Kentucky.

Advisors' Opinion:

• [By Louis Navellier]

  HopFed Bancorp (HFBC), at $85 million in market cap, operates 18 branches in middle Tennessee and Western Kentucky and can be thought of as poster child for what is going on in the small banking sector. An activist investor took a stake in the bank and opposed an ill-advised acquisition. Instead, he suggested HopFed management get its own house in order. Management went along and canceled the deal, instituted a stock buyback plan and doubled the dividend. HFBC was upgraded to an “A” back in May and still is a “strong buy” right now.

Hot Life Sciences Stocks To Invest In 2015: IceWEB Inc (IWEB)

IceWEB, Inc. (IceWEB), incorporated in 1994, manufacture and market unified data storage, purpose built appliances, network and cloud attached storage solutions and deliver on-line cloud computing application services. The Company�� customer base includes the United States government agencies, enterprise companies, and small to medium sized businesses (SMB). The Company has three product offerings: Iceweb Unified Data Network Storage line of products, Purpose Built Network/Data Appliances and Cloud Computing Products/Services. In October 2013, IceWEB Inc completed its acquisition of Computers and Tele-Comm, Inc. and KC-NAP, LLC of Kansas City (collectively CTC).

IceWEB Unified Data Storage line of products

IceWEB is a provider of Unified Data Storage solutions. Its storage systems make it possible to operate and manage files and applications from a single device and consolidate file-based and block-based access in a single storage platform, which supports Fibre Channel SAN, IP-based SAN (iSCSI), and NAS (network attached storage). A unified storage system simultaneously enables storage of file data and handles the block-based I/O (input/output) of enterprise applications. One advantage of unified storage is reduced hardware requirements. The IceWEB Storage System is an all-inclusive storage management system, which includes de-duplication; unlimited snapshots; thin provisioning; local or remote, real-time or scheduled replication; capacity and utilization reporting, and integration with virtual server environments.

Purpose Built Network and Data Appliances

Purpose Built Network and Data Appliances are devices, which provide computing resources (processors and memory), data storage, and specific software for a specific application. The primary appliance products that IceWEB has built have been centered on a single large business partner, ESRI Corporation. IceWEB and ESRI have collaborated to create ultra-high performance IceWEB/ESRI GIS systems tha! t allow customers to access data with speed. ESRI Corporation takes responsibility for marketing to their customers and business partners, via their worldwide sales and consultancy organization.

Cloud Computing Products and Services

Cloud computing products and services consist of cloud computing services and cloud storage appliances. IceWEB provides IceMAIL, a packaged software service that provides network hosted groupware, e-mail, calendaring and collaboration functionality. Online services were expanded to include IcePORTAL, which provides customers with a complete Intranet portal and IceSECURE a hosted e-mail encryption service. Originally such hosted services were referred to as Software-as-a-Service (SaaS). Such services, hosted across the Internet are commonly referred to as Cloud Computing. A cloud storage appliance is a purpose built storage device configured for either branch office or central site deployment, which allows the housing and delivery of customer data across not only their internal networking infrastructure, but also to make that data available to employees or business partners securely via the Internet (often called the cloud).

The Company competes with EMC, Network Appliance, Dell, Hewlett-Packard, Sun Microsystems, Hitachi Data Systems, IBM, Compellent Technologies and Isilon.

Advisors' Opinion:

• [By Peter Graham]

  What�� the Catch with Dephasium Corp? According to various disclosures, transactions of $2k, $2.5k, $3k, $4k, $7.5k, $12.5k and $15k have or will occur to mention Dephasium Corp in various investment newsletters. Dephasium Corp has been getting plenty of off and on attention for a couple of months now, but what�� been pretty strange is the company issuing a press release to announce that an unidentified third party, without the DPHS�� approval, has listed its shares on the Boerse Berlin Stock Exchange. The press release warned that this could be the first salvo in a ��ignificant naked shorting attack directed at the Company��given that the Berlin exchange is one of few stock exchanges in the world that allows listing and trading of a company's stock without the consent or authorization of the company being listed in order to facilitate short-selling. A quick look at Dephasium Corp�� financials reveals no revenues; net losses of $10k (most recent reported quarter), $17k and $11k plus net income of $388k; and $51k to cover $9k in current liabilities at the end of March. In other words, Dephasium Corp isn�� making money but someone else is trying to make some from it.

  IceWEB, Inc. (OTCBB: IWEB) Seems to Be Making Progress

  Small cap IceWEB is a provider of Unified Data Storage appliances for cloud and virtual environments, as well as the highly secure, scalable IceBOXTM BYOD (Bring Your Own Device) Private Digital Cloud Solution. On Friday, IceWEB fell 8.57% to $0.0320 for a market cap of $9.01 million plus IWEB is down 54.3% over the past year and down 81.7% over the past five years according to Google Finance.

• [By Bryan Murphy]

  So far the brewing recovery effort from IceWEB, Inc. (OTCBB:IWEB) has remained off most traders' radars. That may be about to change, however. That's why you may want to go ahead and take a speculative plunge on IWEB now, on faith that the clues we're seeing now will indeed end up as they're suggesting.

Hot Life Sciences Stocks To Invest In 2015: Polypore International Inc(PPO)

Polypore International, Inc., a technology filtration company, develops, manufactures, and markets specialized microporous membranes used in separation and filtration processes. It operates in two segments, Energy Storage and Separations Media. The Energy Storage segment offers membranes that provide the function of separating the cathode and anode in applications, including lithium-ion batteries that are used in portable electronic devices, energy storage systems, cordless power tools, and electric drive vehicles; and lead-acid batteries used in automobiles, other motor vehicles, forklifts, and uninterruptible power supply systems. The Separations Media segment provides membranes that are used as high technology filtration element in various medical and industrial applications. This segment?s membranes and membrane modules are used in applications, such as hemodialysis, blood oxygenation, plasmapheresis and various high-performance microfiltration, ultrafiltration, and g asification/degasification applications. Polypore International, Inc. sells its products to manufacturers and converters who incorporate its products into their finished goods. The company sells its products and services in North America, South America, Europe, and Asia through its direct sales force, and distributors and agents. The company is headquartered in Charlotte, North Carolina.

Advisors' Opinion:

• [By John Udovich]

  When most people think of electric vehicle stocks, they probably think of troubled Tesla Motors Inc (NASDAQ: TSLA) or one of the several Chinese stocks active in the space, but North America based large cap Magna International Inc (NYSE: MGA) and small caps Polypore International, Inc (NYSE: PPO), UQM Technologies Inc (NYSEMKT: UQM) and Green Automotive Company (OTCMKTS: GACR) are all players, one way or the other, in the electric vehicle space that most investors have probably overlooked or just aren�� aware of. Of course, we can argue�about whether or not purely electric vehicles or some sort of hybrid vehicles are the way of the future, but what cannot be argued about is the fact that the following electric vehicle stocks are at the forefront of EV or�hybrid technology and design:

• [By Jake L'Ecuyer]

  Shares of Polypore International (NYSE: PPO) got a boost, shooting up 14.54 percent to $39.77 after the company reported Q1 results. DA Davidson upgraded Polypore from Neutral to Buy and lifted the price target from $36.00 to $42.00.